All In Biotech

Drug Trial Radar · NCT03402945

Prevention of Infections in Cardiac Surgery (PICS) Prevena Study

A Cluster-randomized Factorial Crossover Trial, Comparing Antibiotic Mono-prophylaxis With Cefazolin vs. Dual-prophylaxis With Cefazolin Plus Vancomycin and Conventional Wound Dressing vs. Prevena Negative-pressure Wound Management

Last checked: Nov 19, 2026Latest source record: Feb 28, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 4,107 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

4,107

Actual

Start

Mar 5, 2018

Primary completion

Apr 27, 2023

Study completion Oct 17, 2024

Sponsor

Lead sponsor
Population Health Research InstituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 18, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Crossover
Masking
Single (outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This vanguard study will be conducted at two study sites in Canada. It is a cluster randomized trial to test a combination of two antibiotics for antibiotic prophylaxis as compared to routine prophylaxis with one single antibiotic, and to test a negative-pressure wound management system (Prevena) versus standard wound dressing to reduce chest wound infections.

Conditions

  • Surgical Site Infections

Interventions

  • PrevenaDevice

    Negative-Pressure Wound Management System

  • CefazolinDrug

    antibiotic

  • VancomycinDrug

    antibiotic

  • standard wound dressingOther

    Any non-negative pressure wound dressing that is routinely used at study sites will be considered standard of care in the control arms.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adherence to the wound management systemTime frame: Prevena or standard wound dressing applied after surgery as per protocol, assessed up to 90 days after surgery
  2. Adherence to the antibiotic regimenTime frame: Cefazolin: within an hour of surgery; one intra-operative dose at 4 hours after the first dose or upon wound closure (whatever comes first); two post-operative doses q8h. Vancomycin: initially intravenously; second dose 12 hrs after the first dose.
  3. Loss of follow-upTime frame: up to 90 days after surgery

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Hamilton General Hospital

    Hamilton, Ontario, Canada

  • London Health Sciences Centre & Lawson Health Research Institute

    London, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.